Skip to main content

Table 1 Relative mRNA expression of therapeutic target of Anlotinib in OSCC cell lines

From: METTL3 suppresses anlotinib sensitivity by regulating m6A modification of FGFR3 in oral squamous cell carcinoma

Cell line

VEGFR1

VEGFR2

VEFGFR3

PDGFRβ

FGFR1

FGFR2

FGFR3

FGFR4

c-KIT

HUVECs

1.000

3.896

0.065

0.034

29.590

0.002

0.073

0.008

0.667

HOK

0.335

0.255

0.226

0.401

106.328

2.551

1.861

0.628

0.709

SCC9

0.323

0.032

0.011

0.695

2.211

3.605

11.951

3.400

0.149

SCC15

0.095

0.426

0.074

0.740

1.648

7.160

12.289

3.144

0.005

SCC25

0.025

0.004

0.042

0.806

1.722

9.049

13.947

3.048

0.000

UM1

0.007

0.003

0.009

0.247

1.589

0.710

13.122

3.571

0.005

  1. The VEGFR1 expression level of HUVEC was defined as 1
Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us